Newsletter
Sign up for the Fund's newsletter and get the lastest news, calls and events
| Titel Sort descending | Periode | Program | |
|---|---|---|---|
| Udvikling af Skræddersyede Lægemidler til Behandling af Cancer | 2017 - 2020 | Grand Solutions
|
|
|
Udvikling af Skræddersyede Lægemidler til Behandling af Cancer
Period
2017 - 2020
Region
Region Hovedstaden Program
Grand Solutions Area
Biotek, Medico og Sundhed Investment
Percentage
67.03 Invested
16.4 mill. Budget
24.4 mill. Partners
University of Copenhagen, Nuevolution People
Københavns Universitet
Read more about the project
| |||
| Udvikling og evaluering af målrettede indsatser over for sårbare patienter med type 2-diabetes i socialt udsatte områder i København | 2018 - 2022 | Industrial Researcher
|
|
|
Udvikling og evaluering af målrettede indsatser over for sårbare patienter med type 2-diabetes i socialt udsatte områder i København
Period
2018 - 2022
Region
Region Hovedstaden Program
Erhvervsforsker Area
Biotek, Medico og Sundhed Investment
Percentage
67.18 Invested
1.1 mill. Budget
1.6 mill. Partners
Københavns Universitet, Center for Diabetes, Københavns Kommune People
Center for Diabetes, Københavns Kommune
Read more about the project
| |||
| Use of Deep-learning Convolutional neural network (CNN) to detect bladder lesions – A tool for 'live' identification of pathology and tumor grade - improving the management of patients with non-muscle invasive bladder cancers (NMIBC). | 2020 - 2021 | Innoexplorer
|
|
|
Use of Deep-learning Convolutional neural network (CNN) to detect bladder lesions – A tool for 'live' identification of pathology and tumor grade - improving the management of patients with non-muscle invasive bladder cancers (NMIBC).
Period
2020 - 2021
Region
Region Midtjylland Program
Innoexplorer Area
Biotek, Medico og Sundhed Investment
Percentage
100 Invested
1.5 mill. Budget
1.5 mill. Partners
Århus Universitetshospital People
Århus Universitetshospital
Read more about the project
| |||
| Use of non-classical bioisosteres in drug discovery | 2019 - 2021 | Industrial Researcher
|
|
|
Use of non-classical bioisosteres in drug discovery
Period
2019 - 2021
Region
Region Hovedstaden Program
Erhvervsforsker Area
Biotek, Medico og Sundhed Investment
Percentage
73.27 Invested
828.000 Budget
1.1 mill. Partners
University of Copenhagen, H LUNDBECK A/S People
H LUNDBECK A/S
Read more about the project
| |||
| Use of the human beta cell line EndoC-bH1 to generate a valid and reproducible model of human beta cells under type 2 diabetic stress | 2015 - 2020 | Industrial Researcher
|
|
|
Use of the human beta cell line EndoC-bH1 to generate a valid and reproducible model of human beta cells under type 2 diabetic stress
Period
2015 - 2020
Region
Region Hovedstaden Program
Erhvervsforsker Area
Biotek, Medico og Sundhed Investment
Percentage
52.68 Invested
1.1 mill. Budget
2.0 mill. Partners
University of Copenhagen, Novo Nordisk A/S People
Novo Nordisk A/S
Read more about the project
| |||
| User-symbiotic speech enhancement for hearing aid systems | 2018 - 2021 | Industrial Researcher
|
|
|
User-symbiotic speech enhancement for hearing aid systems
Period
2018 - 2021
Region
Region Hovedstaden Program
Erhvervsforsker Area
Biotek, Medico og Sundhed Investment
Percentage
43.67 Invested
1.1 mill. Budget
2.5 mill. Partners
Aalborg Universitet, OTICON A/S People
OTICON A/S
Read more about the project
| |||
| UV-light disinfection of venous catheters | 2019 - 2020 | Innobooster
|
|
|
UV-light disinfection of venous catheters
Period
2019 - 2020
Region
Region Sjælland Program
Innobooster Area
Biotek, Medico og Sundhed Investment
Percentage
30.46 Invested
499.000 Budget
1.6 mill. Partners
UV Clinical People
UV Clinical ApS
Read more about the project
| |||
| Vaccine Expanded Human T cells Targeting Endogenous Retrovirus-K in Human Cancer Cells | 2019 - 2022 | Industrial Researcher
|
|
|
Vaccine Expanded Human T cells Targeting Endogenous Retrovirus-K in Human Cancer Cells
Period
2019 - 2022
Region
Region Hovedstaden Program
Erhvervsforsker Area
Biotek, Medico og Sundhed Investment
Percentage
42.03 Invested
1.1 mill. Budget
2.6 mill. Partners
University of Copenhagen, INPROTHER ApS People
INPROTHER ApS
Read more about the project
| |||
| Validation of novel detoxification platform turning bacterial toxins into vaccine antigens | 2019 - 2020 | Innobooster
|
|
|
Validation of novel detoxification platform turning bacterial toxins into vaccine antigens
Period
2019 - 2020
Region
Region Hovedstaden Program
Innobooster Area
Biotek, Medico og Sundhed Investment
Percentage
27.8 Invested
496.000 Budget
1.8 mill. Partners
Proxi Biotech People
PrOxi Biotech ApS
Read more about the project
| |||
| Validering af biologisk sikkerhed og toksikologiske effekter i realtid | 2020 - 2020 | Innobooster
|
|
|
Validering af biologisk sikkerhed og toksikologiske effekter i realtid
Period
2020 - 2020
Region
Region Hovedstaden Program
Innobooster Area
Biotek, Medico og Sundhed Investment
Percentage
33 Invested
495.000 Budget
1.5 mill. Partners
SAXOCON A/S People
SAXOCON A/S
Read more about the project
| |||
| Vascurion - Therapeutic application of powerful vasodilators | 2020 - 2021 | Innoexplorer
|
|
|
Vascurion - Therapeutic application of powerful vasodilators
Period
2020 - 2021
Region
Region Hovedstaden Program
Innoexplorer Area
Biotek, Medico og Sundhed Investment
Percentage
100 Invested
1.2 mill. Budget
1.2 mill. Partners
Rigshospitalet - Glostrup People
Rigshospitalet - Glostrup
Read more about the project
| |||
| Version Equipment Manager (VEM) | 2020 - 2020 | Innobooster
|
|
|
Version Equipment Manager (VEM)
Period
2020 - 2020
Region
Region Hovedstaden Program
Innobooster Area
Biotek, Medico og Sundhed Investment
Percentage
33 Invested
1.5 mill. Budget
4.5 mill. Partners
VEM ApS People
VEM ApS
Read more about the project
| |||
| Vi vil D - Implementering af evidensbaseret praksis | 2020 - 2022 | Industrial Researcher
|
|
|
Vi vil D - Implementering af evidensbaseret praksis
Period
2020 - 2022
Region
Region Hovedstaden Program
Erhvervsforsker Area
Biotek, Medico og Sundhed Investment
Percentage
57.72 Invested
1.0 mill. Budget
1.8 mill. Partners
Københavns Universitet, Københavns Professionshøjskole People
Københavns Professionshøjskole
Read more about the project
| |||
| VIA 11 Innovation - The Danish High Risk and Resilience Study | 2018 - 2021 | Grand Solutions
|
|
|
VIA 11 Innovation - The Danish High Risk and Resilience Study
Period
2018 - 2021
Region
Region Hovedstaden Program
Grand Solutions Area
Biotek, Medico og Sundhed Investment
Percentage
71.76 Invested
11.0 mill. Budget
15.4 mill. Partners
Region Hovedstadens psykiatri, Aarhus University Hospital, Risskov, Child and Adolescent Mental Health Centre, Mental Health Services Capital Region., Amager og Hvidovre Hospital, Institute for Clinical Medicin, Aarhus University, Khora Virtual Reality, Sens Innovation ApS People
Mental Health Center Copenhagen
Read more about the project
| |||
| Vidensopbygning til godkendelsesprocess (inkl. usability tests) for Medical Device kat. 1 (ny opfindelse). | 2020 - 2023 | Innobooster
|
|
|
Vidensopbygning til godkendelsesprocess (inkl. usability tests) for Medical Device kat. 1 (ny opfindelse).
Period
2020 - 2023
Region
Region Sjælland Program
Innobooster Area
Biotek, Medico og Sundhed Investment
Percentage
33 Invested
378.180 Budget
1.1 mill. Partners
Design4liva People
Design4Liva
Read more about the project
| |||